mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |